Paid Clinical Trials in Houma, LA
As of August 2026, 39 paid clinical trials are recruiting in Houma, Louisiana. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Houma offers studies at sites including Cardiovascular Institute of the South for conditions such as Heart Failure, Cardiovascular Diseases, Crohn's Disease, Heart Valve Diseases. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Houma
Trials by drug in Houma
Filter results
34 clinical trials
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
The CONFORM Pivotal Trial
SELUTION 4 De Novo Small Vessel IDE Trial
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
ELEVATE-HFpEF Clinical Study
The THOR IDE Study
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
J-Valve Transfemoral Pivotal Study
TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
The ArtixASCEND Study
ATLAS (AltaValve) Pivotal Trial
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mobile Health for Adherence in Breast Cancer Patients
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Collaborative Multi-level Obesity Intervention Engaging Underserved Communities Trial
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Top Research Study Locations in Houma
Researchers run research studies in Houma, LA at 16 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Cardiovascular Institute of the South | Heart Failure, Cardiovascular Diseases, Hypertension | 18 |
| Terrebonne General Medical Center | Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Anatomic Stage IV Breast Cancer AJCC v8 | 5 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| Tandem Clinical Research | Crohn's Disease, Inflammatory Bowel Diseases, Metabolic Dysfunction-associated Steatohepatitis | 2 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 1 |
| CIS Clinical Research | Iliofemoral; Thrombosis, Thrombosis, Deep Vein | 1 |
| CV Institute of the South | Cardiovascular Disease and Lipoprotein(a) | 1 |
| Cardiovascular Institute South | Cardiovascular Diseases, Functional Mitral Regurgitation, Heart Diseases | 1 |
| Cardiovascular Institute of the South - Houma | Peripheral Arterial Disease | 1 |
| GSK Investigational Site | Irritable Bowel Syndrome | 1 |
| Tandem Clinical Research GI - Houma | Chronic Idiopathic Constipation (CIC) | 1 |
| Tandem Intermediate, LLC - Houma | Ulcerative Colitis | 1 |
| Tandem Intermediate, LLC - Houma | Crohn's Disease | 1 |
| Teche Action Clinic - Houma | Obesity | 1 |
| Terrebone - Cardiovascular Institute of the South | Atrial Fibrillation, Stroke | 1 |
| Terrebonne General Hospital/Cardiovascular Institute of the South | Acute Lower Limb Arterial Occlusion | 1 |
Active & Upcoming Studies in Houma (2026)
Recruiting trials in Houma grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cardiovascular (13 active studies)
- A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation. · P+F Products + Features USA Inc.
- A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease · Pulnovo Medical, Inc.
Cancer & tumors (5 active studies)
- Mobile Health for Adherence in Breast Cancer Patients · ECOG-ACRIN Cancer Research Group
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection · Alliance for Clinical Trials in Oncology
Diabetes & metabolic (5 active studies)
Neurology & pain (1 active study)
- The CONFORM Pivotal Trial · Conformal Medical, Inc
Common conditions studied in Houma
- Heart Failure (8 active studies)
- Cardiovascular Diseases (3 active studies)
- Crohn's Disease (2 active studies)
- Heart Valve Diseases (2 active studies)
- Hypertension (2 active studies)
- Obesity (2 active studies)
Leading research sponsors in Houma
- Akero Therapeutics, Inc
- Alleviant Medical, Inc.
- Mercator MedSystems, Inc.
- P+F Products + Features USA Inc.
- Sanofi
Frequently asked questions
How many paid clinical trials are currently recruiting in Houma?
There are approximately 39 recruiting clinical trials in Houma, Louisiana listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Houma pay participants?
Most recruiting trials in Houma compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Houma?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Houma?
The most common conditions under active study in Houma include Heart Failure (8), Cardiovascular Diseases (3), Crohn's Disease (2), Heart Valve Diseases (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Houma?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Houma on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Houma?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Houma?
Recruiting research sites in Houma include Cardiovascular Institute of the South, Terrebonne General Medical Center, Akero Clinical Study Site, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Houma right now?
The largest active categories in Houma are Cardiovascular (13), Cancer & tumors (5), Diabetes & metabolic (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.